Sally Cheshire, Julie Stone and Dr Allison Jeynes-Ellis have today been confirmed as Non-Executive Directors of the Health Research Authority (HRA). Sally will also be the Audit Committee Chair.
The new Non-Executive Directors will support the Chair by contributing to the effective governance of the Health Research Authority.
Health Secretary Andrew Lansley said:
“I am very pleased to announce the appointment to the Health Research Authority of Sally Cheshire as Non-Executive Director and Audit Committee Chair and Julie Stone and Dr Allison Jeynes-Ellis as Non-Executive Directors.
“These appointments, together with the recent appointment of the Chair and Chief Executive, bring a depth of knowledge and experience that is essential in leading the Health Research Authority to safeguard the safety and interests of patients whilst streamlining health research regulation and further supporting England as the best location for life sciences in Europe.”
Professor Dame Sally C. Davies, Chief Medical Officer and Chief Scientific Advisor, Department of Health said:
”I am delighted that these appointments have been made and that the full board has now been established. With its non-executive majority board, the Health Research Authority has greater independence so that patients and the public can be even more confident about its work, as well as the research they take part in and benefit from. I wish the HRA every success in driving forward its objectives to protect and promote the interests of patients and the public in health research.”
Professor Jonathan Montgomery, Chair of the Health Research Authority, said:
“I am delighted that the HRA Board has secured such talented non-executive directors. With their collective experience of the NHS, national regulatory functions, industry and public and patient interests, the new directors are well placed to drive forward our work in protecting and promoting the interests of those involved in health research.”
Notes to editors
For media enquiries please ring Sean Kenny at the Department of Health press office on 0207 210 4939.
Sally Cheshire has spent 13 years as a Consulting Director with one of the leading global professional services firms and is a Chartered Management Accountant by profession. She is currently Vice Chair of NHS North England and Audit Chair of the Human Fertilisation and Embryology Authority.
Julie Stone is a medico-legal, ethical and regulatory academic and policy advisor. She is currently a Non-Executive Director of NHS Cornwall and Isles of Scilly, lay member of the General Osteopathic Council and member of the Ministerial Advisory Group on Mental Health Strategy.
Dr Allison Jeynes-Ellis is a senior pharmaceutical physician with experience of working in the life sciences industry and a research and development specialist in oncology. Her current roles include Independent Pharmaceutical Consultant working across the life sciences and member of the General Medical Council.
These appointments are made in accordance with the Code of Practice for ministerial appointments to public bodies, issued by the Commissioner for Public Appointments. All appointments are made on merit and political activity played no part in the selection process. However, in accordance with the original Nolan recommendations, there is a requirement for appointees’ political activity (if any declared) to be made public. All have declared no political activity. For further information on the process for managing public appointments visit The Commissioner for Public Appointments website.
- Sally Cheshire and Julie Stone will be appointed for four years and Dr Alison Jeynes-Ellis for two years. These appointments are for a time commitment of between two and three days per month. Remuneration for the roles is offered at a rate of £13,137 per annum for the Audit Committee Chair and £7,883 per annum for the other Non-Executive Directors.
- For further information on the Health Research Authority visit their website.